Consequences of oral antithrombotic use in patients with chronic kidney disease

• Main Authors: Solène M. Laville (Author), Oriane Lambert (Author), Aghiles Hamroun (Author), Marie Metzger (Author), Christian Jacquelinet (Author), Maurice Laville (Author), Luc Frimat (Author), Denis Fouque (Author), Christian Combe (Author), Carole Ayav (Author), Roberto Pecoits‐Filho (Author), Bénédicte Stengel (Author), Ziad A. Massy (Author), Sophie Liabeuf (Author), the CKD‐REIN Study Collaborators (Author)
• Formato: Livro
• Publicado em: Wiley, 2021-11-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Abstract We assessed the risks of bleeding, acute kidney injury (AKI), and kidney failure associated with the prescription of antithrombotic agents (oral anticoagulants and/or antiplatelet agents) in patients with moderate‐to‐advanced chronic kidney disease (CKD). CKD‐REIN is a prospective cohort of...